Diagnostik und Therapie vestibulärer Störungen

Lernziele

Vertiefung der Kenntnisse zur Anamneseerhebung beim Leitsymptom Schwindel Verbesserung der praktischen Fertigkeiten zur körperlichen Untersuchung des vestibulären Systems, insbesondere des vestibulookulären Reflexes und Durchführung der Lagerungsmanöver Darstellung der Diagnose und Therapie der häufigsten peripheren und zentralen vestibulären Syndrome

Literatur

• 1 Neuhauser H K. Epidemiology of vertigo.  Curr Opin Neurol. 2007;  20 40-46
• 2 Brandt T, Dieterich M, Strupp M. Vertigo – Leitsymptom Schwindel. 2. Auflage. Darmstadt; Steinkopff 2010
• 3 Leigh R J, Zee D. The neurology of eye movements, 4 ed. Oxford, New York; Oxford University Press 2006
• 4 Halmagyi G M, Curthoys I S. A clinical sign of canal paresis.  Arch Neurol. 1988;  45 737-739
• 5 Zwergal A, Rettinger N, Frenzel C. et al . A bucket of static vestibular function.  Neurology. 2009;  72 1689-1692
• 6 Karlberg M, Hall K, Quickert N. et al . What inner ear diseases cause benign paroxysmal positional vertigo?.  Acta Oto Laryngol. 2000;  120 380-385
• 7 Brandt T, Steddin S. Current view of the mechanism of benign paroxysmal positioning vertigo: cupulolithiasis or canalolithiasis?.  J Vestib Res. 1993;  3 373-382
• 8 Brandt T, Steddin S, Daroff R B. Therapy for benign paroxysmal positioning vertigo, revisited.  Neurology. 1994;  44 796-800
• 9 Semont A, Freyss G, Vitte E. Curing the BPPV with a liberatory maneuver.  Adv Otorhinolaryngol. 1988;  42 290-293
• 10 Epley J M. The canalith repositioning procedure: for treatment of benign paroxysmal positional vertigo.  Otolaryngol Head Neck Surg. 1992;  107 399-404
• 11 Strupp M, Cnyrim C, Brandt T. Vertigo and dizziness: treatment of benign paroxysmal positioning vertigo, vestibular neuritis and Menière's disease. In: Candelise L, ed Evidence-Based Neurology – Management of Neurological Disorders. Oxford; Blackwell Publishing 2007: 59-69
• 12 Brandt T, Huppert D, Hecht J. et al . Benign paroxysmal positioning vertigo: a long-term follow-up (6–17 years) of 125 patients.  Acta Otolaryngol. 2006;  126 160-163
• 13 Minor L B, Schessel D A, Carey J P. Menière's disease.  Curr Opin Neurol. 2004;  17 9-16
• 14 Sajjadi H, Paparella M M. Menière's disease.  Lancet. 2008;  372 406-414
• 15 Strupp M, Huppert D, Frenzel C. et al . Long-term prophylactic treatment of attacks of vertigo in Menière's disease – comparison of a high with a low dosage of betahistine in an open trial.  Acta Otolaryngol (Stockh). 2008;  128 620-624
• 16 Theil D, Arbusow V, Derfuss T. et al . Prevalence of HSV-1 LAT in human trigeminal, geniculate, and vestibular ganglia and its implication for cranial nerve syndromes.  Brain Pathol. 2001;  11 408-413
• 17 Strupp M, Zingler V C, Arbusow V. et al . Methylprednisolone, valacyclovir, or the combination for vestibular neuritis.  N Engl J Med. 2004;  351 354-361
• 18 Strupp M, Arbusow V, Maag K P. et al . Vestibular exercises improve central vestibulospinal compensation after vestibular neuritis.  Neurology. 1998;  51 838-844
• 19 Neuhauser H, Leopold M, von Brevern M. et al . The interrelations of migraine, vertigo, and migrainous vertigo.  Neurology. 2001;  56 436-441
• 20 Dieterich M, Brandt T. Episodic vertigo related to migraine (90 cases): vestibular migraine?.  J Neurol. 1999;  246 883-892
• 21 Baier B, Winkenwerder E, Dieterich M. „Vestibular migraine”: effects of prophylactic therapy with various drugs. A retrospective study.  J Neurol. 2009;  256 436-442
• 22 Best C, Eckhardt-Henn A, Tschan R. et al . Psychiatric morbidity and comorbidity in different vestibular vertigo syndromes. Results of a prospective longitudinal study over one year.  J Neurol. 2009;  256 58-65
• 23 Eckhardt-Henn A, Best C, Bense S. et al . Psychiatric comorbidity in different organic vertigo syndromes.  J Neurol. 2008;  255 420-428
• 24 Wagner J N, Glaser M, Brandt T. et al . Downbeat nystagmus: aetiology and comorbidity in 117 patients.  J Neurol Neurosurg Psychiatry. 2008;  79 672-679
• 25 Kalla R, Deutschlander A, Hufner K. et al . Detection of floccular hypometabolism in downbeat nystagmus by fMRI.  Neurology. 2006;  66 281-283
• 26 Strupp M, Schuler O, Krafczyk S. et al . Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.  Neurology. 2003;  61 165-170
• 27 Kalla R, Glasauer S, Buttner U. et al . 4-Aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus.  Brain. 2007;  130 2441-2451
• 28 Glasauer S, Kalla R, Buttner U. et al . 4-aminopyridine restores visual ocular motor function in upbeat nystagmus.  J Neurol Neurosurg Psychiatry. 2005;  76 451-453
• 29 Strupp M, Kalla R, Dichgans M. et al . Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine.  Neurology. 2004;  62 1623-1625
• 30 Brandt T, Dieterich M. Phobischer Attacken-Schwankschwindel, ein neues Syndrom.  Münch Med Wochenschr. 1986;  128 247-250
• 31 Brandt T. Phobic postural vertigo.  Neurology. 1996;  46 1515-1519
• 32 Brandt T, Huppert D, Dieterich M. Phobic postural vertigo: a first follow-up.  J Neurol. 1994;  241 191-195
• 33 Kapfhammer H P, Mayer C, Hock U. et al . Course of illness in phobic postural vertigo.  Acta Neurol Scand. 1997;  95 23-28
• 34 Pollak L, Klein C, Stryjer R. et al . Phobic postural vertigo: a new proposed entity.  Isr Med Assoc J. 2003;  5 720-723
• 35 Huppert D, Strupp M, Rettinger N. et al . Phobic postural vertigo – a long-term follow-up (5 to 15 years) of 106 patients.  J Neurol. 2005;  252 564-569
• 36 Holmberg J, Karlberg M, Harlacher U. et al . Treatment of phobic postural vertigo. A controlled study of cognitive-behavioral therapy and self-controlled desensitization.  J Neurol. 2006;  253 500-506
• 37 Holmberg J, Karlberg M, Harlacher U. et al . One-year follow-up of cognitive behavioral therapy for phobic postural vertigo.  J Neurol. 2007;  254 II89-II92